Pluribus Labs’s B&G Foods BGS Stock Holding History

Pluribus Labs’s Portfolio BGS Stock Details BGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-10,934	Closed	-$336K	–	73
2021 Q4	$336K	Buy	+10,934	New	+$334K	0.35%	111

Other funds holding BGS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Pluribus Labs's BGS Position: Q1 2022 in Review

Pluribus Labs sold out of B&G Foods (BGS) in Q1 2022, closing a stake of 10,934 shares — an estimated $336K sold.

Pluribus Labs first reported a position in BGS in Q4 2021 and held it in 1 quarter. The position peaked at $336K in Q4 2021. 314 funds tracked by Wall St. Rank hold BGS as of Q1 2022.

Pluribus Labs reported no remaining B&G Foods position as of Q1 2022 after selling out during the quarter.
Pluribus Labs sold 10,934 B&G Foods shares in Q1 2022, an estimated $336K.
Pluribus Labs first reported a position in B&G Foods in Q4 2021 and held it in 1 quarter.
Pluribus Labs's B&G Foods position peaked at $336K in Q4 2021.
314 funds tracked by Wall St. Rank held B&G Foods as of Q1 2022.

Based on Pluribus Labs's 13F filing for Q1 2022, filed 16 May 2022.